Patents by Inventor Wendy A. Young
Wendy A. Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11782488Abstract: Methods and apparatus to operate closed-lid portable computers are disclosed. An example portable compute device includes: a microphone; a speaker; a first camera to face a first direction; and a second camera to face a second direction, the second direction opposite the first direction. The compute device further includes communications circuitry; a first display; a second display separate from the first display; and a hinge to enable the first display to rotate relative to the second display between an open position and a closed position. At least a portion of the second display is capable of being visible when the first display is rotated about the hinge to the closed position. The portion of the second display is multiple times longer in a third direction than in a fourth direction perpendicular to the third direction, the third direction extending parallel to an axis of rotation of the hinge.Type: GrantFiled: July 1, 2022Date of Patent: October 10, 2023Assignee: INTEL CORPORATIONInventors: Barnes Cooper, Aleksander Magi, Arvind Kumar, Giuseppe Raffa, Wendy March, Marko Bartscherer, Irina Lazutkina, Duck Young Kong, Meng Shi, Vivek Paranjape, Vinod Gomathi Nayagam, Glen J. Anderson
-
Patent number: 11740666Abstract: Methods and apparatus to operate closed-lid portable computers are disclosed. An example portable compute device includes: a microphone; a speaker; a first camera to face a first direction; and a second camera to face a second direction, the second direction opposite the first direction. The compute device further includes communications circuitry; a first display; a second display separate from the first display; and a hinge to enable the first display to rotate relative to the second display between an open position and a closed position. At least a portion of the second display is capable of being visible when the first display is rotated about the hinge to the closed position. The portion of the second display is multiple times longer in a third direction than in a fourth direction perpendicular to the third direction, the third direction extending parallel to an axis of rotation of the hinge.Type: GrantFiled: July 1, 2022Date of Patent: August 29, 2023Assignee: INTEL CORPORATIONInventors: Barnes Cooper, Aleksander Magi, Arvind Kumar, Giuseppe Raffa, Wendy March, Marko Bartscherer, Irina Lazutkina, Duck Young Kong, Meng Shi, Vivek Paranjape, Vinod Gomathi Nayagam, Glen J. Anderson
-
Publication number: 20230236642Abstract: Methods and apparatus to operate closed-lid portable computers are disclosed. An example portable computer includes a first display on a lid of the portable computer, the first display to be deactivated when the lid is in a closed position; a second display distinct from the first display, the second display to be visible when the lid is in the closed position; instructions; and processor circuitry to execute the instructions to cause activation of the first display in response to a user interaction with the second display while the lid is in the closed position.Type: ApplicationFiled: January 27, 2023Publication date: July 27, 2023Inventors: Barnes Cooper, Aleksander Magi, Arvind Kumar, Giuseppe Raffa, Wendy March, Marko Bartscherer, Irina Lazutkina, Duck Young Kong, Meng Shi, Vivek Paranjape, Vinod Gomathi Nayagam, Glen J. Anderson
-
Patent number: 10344040Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: GrantFiled: February 26, 2018Date of Patent: July 9, 2019Assignees: GILEAD CONNECTICUT, INC., GENENTECH INC.Inventors: Antonio J. M. Barbosa, Peter A. Blomgren, Kevin S. Currie, Ravi Krishnamoorthy, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Daniel Ortwine, Aaron C. Schmitt, Xiaojing Wang, Jianjun Xu, Wendy Young, Honglu Zhang, Zhongdong Zhao, Pavel E. Zhichkin
-
Patent number: 10053469Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: GrantFiled: September 30, 2016Date of Patent: August 21, 2018Assignees: GILEAD CONNECTICUT, INC., GENENTECH INC.Inventors: Antonio J. M. Barbosa, Peter A. Blomgren, Kevin S. Currie, Ravi Krishnamoorthy, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Daniel Ortwine, Aaron C. Schmitt, Xiaojing Wang, Jianjun Xu, Wendy Young, Honglu Zhang, Zhongdong Zhao, Pavel E. Zhichkin
-
Publication number: 20180179229Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: ApplicationFiled: February 26, 2018Publication date: June 28, 2018Applicants: GILEAD CONNECTICUT, INC., GENENTECH INC.Inventors: Antonio J.M. BARBOSA, Peter A. BLOMGREN, Kevin S. CURRIE, Ravi KRISHNAMOORTHY, Jeffrey E. KROPF, Seung H. LEE, Scott A. MITCHELL, Daniel ORTWINE, Aaron C. SCHMITT, Xiaojing WANG, Jianjun XU, Wendy YOUNG, Honglu ZHANG, Zhongdong ZHAO, Pavel E. ZHICHKIN
-
Publication number: 20170073356Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in intro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: ApplicationFiled: September 30, 2016Publication date: March 16, 2017Applicants: GILEAD CONNECTICUT, INC., GENENTCH INC.Inventors: Antonio J.M. BARBOSA, Peter A. BLOMGREN, Kevin S. CURRIE, Ravi KRISHNAMOORTHY, Jeffrey E. KROPF, Seung H. LEE, Scott A. MITCHELL, Daniel ORTWINE, Aaron C. SCHMITT, Xiaojing WANG, Jianjun XU, Wendy YOUNG, Honglu ZHANG, Zhongdong ZHAO, Pavel E. ZHICHKIN
-
Patent number: 9505785Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: GrantFiled: October 22, 2013Date of Patent: November 29, 2016Assignees: Gilead Connecticut, Inc., Genentech, Inc.Inventors: Antonio J. M. Barbosa, Peter A. Blomgren, Kevin S. Currie, Ravi Krishnamoorthy, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Daniel Ortwine, Aaron C. Schmitt, Xiaojing Wang, Jianjun Xu, Wendy Young, Honglu Zhang, Zhongdong Zhao, Pavel E. Zhichkin
-
Patent number: 8663155Abstract: A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.Type: GrantFiled: February 2, 2006Date of Patent: March 4, 2014Assignee: Alza CorporationInventors: Michel J. N. Cormier, Wendy A. Young, Kofi Nyam, Peter E. Daddona, Wei-Qi Lin
-
Publication number: 20140057896Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: ApplicationFiled: October 22, 2013Publication date: February 27, 2014Inventors: Antonio J.M. BARBOSA, Peter A. BLOMGREN, Kevin S. CURRIE, Ravi KRISHNAMOORTHY, Jeffrey E. KROPF, Seung H. LEE, Scott A. MITCHELL, Daniel ORTWINE, Aaron C. SCHMITT, Xiaojing WANG, Jianjun XU, Wendy YOUNG, Honglu ZHANG, Zhongdong ZHAO, Pavel E. ZHICHKIN
-
Patent number: 8618107Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: GrantFiled: May 6, 2011Date of Patent: December 31, 2013Assignees: Gilead Connecticut, Inc., Genentech, Inc.Inventors: Antonio J. M. Barbosa, Peter A. Blomgren, Kevin S. Currie, Ravi Krishnamoorthy, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Daniel Ortwine, Aaron C. Schmitt, Xiaojing Wang, Jianjun Xu, Wendy Young, Honglu Zhang, Zhongdong Zhao, Pavel E. Zhichkin
-
Publication number: 20120010191Abstract: Pyridone and aza-pyridone compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.Type: ApplicationFiled: May 6, 2011Publication date: January 12, 2012Applicants: GENENTECH, INC., GILEAD CONNECTICUT, INC.Inventors: Antonio J.M. BARBOSA, Peter A. Blomgren, Kevin S. Currie, Ravi Krishnamoorthy, Jeffrey E. Kropf, Seung H. Lee, Scott A. Mitchell, Daniel Ortwine, Aaron C. Schmitt, Xiaojing Wang, Jianjun Xu, Wendy Young, Honglu Zhang, Zhongdong Zhao, Pavel E. Zhichkin
-
Patent number: 7963935Abstract: The device including a plurality of stratum corneum-piercing microprojections, and a solid coating disposed upon the microprojections, wherein the solid coating includes at least one beneficial agent and a biocompatible carrier is provided. The device is applied to the skin of a living animal (e.g., a human), causing the microprojections to pierce the stratum corneum and deliver an effective dose of the agent to the animal.Type: GrantFiled: April 20, 2002Date of Patent: June 21, 2011Assignee: Alza CorporationInventors: Michel J. N. Cormier, Wendy A. Young, Juanita A. Johnson, Peter E. Daddona
-
Patent number: 7801599Abstract: A transdermal electrotransport drug delivery device having an anode, a cathode and a source of electrical power electrically connected to the anode and the cathode. At least one of the anode and the cathode includes an electrode and a reservoir comprised of a housing composed of a polymeric material and an aqueous medium in contact with the housing. The aqueous medium includes (i) a drug or an electrolyte salt or a mixture thereof, (ii) propylene glycol, and (iii) an antimicrobial agent in an amount sufficient to inhibit microbial growth in the aqueous medium. The propylene glycol prevents the antimicrobial agent from being adsorbed by other materials used in the construction of the delivery device. A process for preparing a transdermal electrotransport drug delivery device is also provided.Type: GrantFiled: November 3, 2006Date of Patent: September 21, 2010Assignee: Alza CorporationInventors: Wendy A. Young, Michel J. Cormier
-
Patent number: 7761147Abstract: A transdermal electrotransport drug delivery device having an anode, a cathode and a source of electrical power electrically connected to the anode and the cathode. At least one of the anode and the cathode includes an electrode and a reservoir comprised of a housing composed of a polymeric material and an aqueous medium in contact with the housing. The aqueous medium includes (i) a drug or an electrolyte salt or a mixture thereof, (ii) propylene glycol, and (iii) an antimicrobial agent in an amount sufficient to inhibit microbial growth in the aqueous medium. The propylene glycol prevents the antimicrobial agent from being adsorbed by other materials used in the construction of the delivery device. A process for preparing a transdermal electrotransport drug delivery device is also provided.Type: GrantFiled: March 18, 2005Date of Patent: July 20, 2010Assignee: ALZA CorporationInventors: Wendy A. Young, Michel J. N. Cormier
-
Publication number: 20100152242Abstract: A transdermal electrotransport drug delivery device having an anode, a cathode and a source of electrical power electrically connected to the anode and the cathode. At least one of the anode and the cathode includes an electrode and a reservoir comprised of a housing composed of a polymeric material and an aqueous medium in contact with the housing. The aqueous medium includes (i) a drug or an electrolyte salt or a mixture thereof, (ii) propylene glycol, and (iii) an antimicrobial agent in an amount sufficient to inhibit microbial growth in the aqueous medium. The propylene glycol prevents the antimicrobial agent from being adsorbed by other materials used in the construction of the delivery device. A process for preparing a transdermal electrotransport drug delivery device is also provided.Type: ApplicationFiled: February 24, 2010Publication date: June 17, 2010Applicant: ALZA CorporationInventors: Wendy A. Young, Michel J.N. Cormier
-
Publication number: 20090186147Abstract: Methods are provided for preparation of a coating on one or more microprojections of a microprojection array using wetting agents either as a pretreatment of the microprojection surfaces or incorporated in the coating formulation along with the active agent.Type: ApplicationFiled: October 31, 2008Publication date: July 23, 2009Applicant: Alza CorporationInventors: Michel J.N. Cormier, Wendy A. Young, Juanita A. Johnson, Peter E. Daddona, Mahmoud Armeri
-
Publication number: 20090143724Abstract: Skin patches (20) having a microprojection array (10), a reservoir (18) containing an antigenic agent and an immune response augmenting adjuvant, and methods of using same to vaccinate animals (e.g., humans) is disclosed. In a preferred embodiment, the microprojection arrays (10) are composed of a photoetched and micro-punched titanium foil (14). The microprojections (12) are coated with a liquid formulation containing a vaccine antigen and an adjuvant such as glucosaminyl muramyl dipeptide, dried, and applied to skin of the animal to be vaccinated using an impact applicator. The microprojections (12) create superficial pathways through the stratum corneum to facilitate permeation of antigenic agent and adjuvant. Antigen dose and depth of penetration can be controlled. This technology has broad applicability for a wide variety of therapeutic vaccines to improve efficacy, and convenience of use.Type: ApplicationFiled: February 6, 2009Publication date: June 4, 2009Applicant: Alza CorporationInventors: Michel J.N. Cormier, James A. Matriano, Peter E. Daddona, Juanita A. Johnson, Wendy A. Young
-
Patent number: 7537795Abstract: A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.Type: GrantFiled: October 26, 2001Date of Patent: May 26, 2009Assignee: Alza CorporationInventors: Michel J. N. Cormier, Wendy A. Young, Kofi Nyam, Peter E. Daddona
-
Publication number: 20090036822Abstract: An electrotransport device for delivering or sampling an agent through a body surface by electrotransport, the device having a housing including an upper, exterior housing portion and a lower housing portion, the housing enclosing electronic components, and at least one hydratable or hydrated reservoir containing water or an at least partially aqueous solution of the agent. At least a portion of the housing is composed of an ethylene-octene copolymer.Type: ApplicationFiled: October 7, 2008Publication date: February 5, 2009Applicant: ALZA CorporationInventors: Lothar W. Kleiner, Wendy A. Young